1. Johnson, Marc O, Wolf, Melissa M, Madden, Matthew Z, Blazar, Bruce R, Rathmell, Jeffrey C. 2018. Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism. In Cell, 175, 1780-1795.e19. doi:10.1016/j.cell.2018.10.001. https://pubmed.ncbi.nlm.nih.gov/30392958/
2. Chen, Yichen, Wang, Jun, Wang, Xi, Cheng, Bin, Wang, Zhi. 2019. Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity. In Clinical cancer research : an official journal of the American Association for Cancer Research, 25, 6180-6194. doi:10.1158/1078-0432.CCR-18-4134. https://pubmed.ncbi.nlm.nih.gov/31350312/
3. Xie, Wenqiang, Fang, Juan, Shan, Zhongyan, Chen, Qianming, Wang, Zhi. 2022. Regulation of autoimmune disease progression by Pik3ip1 through metabolic reprogramming in T cells and therapeutic implications. In Science advances, 8, eabo4250. doi:10.1126/sciadv.abo4250. https://pubmed.ncbi.nlm.nih.gov/36179018/
4. Ma, Xu-Bin, Wang, Yang, Jia, Ying-Jie, Xu, Yi-Chao, Liu, Hong-Min. 2022. Upregulation of PIK3IP1 monitors the anti-cancer activity of PI3Kα inhibitors in gastric cancer cells. In Biochemical pharmacology, 207, 115380. doi:10.1016/j.bcp.2022.115380. https://pubmed.ncbi.nlm.nih.gov/36521557/
5. Sloan, Shelby L, Brown, Fiona, Long, Mackenzie, Baiocchi, Robert A, Alinari, Lapo. . PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma. In Blood, 142, 887-902. doi:10.1182/blood.2022019419. https://pubmed.ncbi.nlm.nih.gov/37267517/
6. Lee, Kyunghee, Kitagawa, Mayumi, Liao, Pei Ju, Virshup, David M, Lee, Sang Hyun. 2020. A Ras-LSD1 axis activates PI3K signaling through PIK3IP1 suppression. In Oncogenesis, 9, 2. doi:10.1038/s41389-019-0185-4. https://pubmed.ncbi.nlm.nih.gov/31900384/
智鼠故事 
